by Betsy McCallon, Chief Executive Officer, White Ribbon Alliance
Since our beginnings nearly 20 years ago, White Ribbon Alliance has brought diverse partners together to advance reproductive and maternal health and rights for women and girls. It’s always exciting to witness community, national and global partners bring their unique talents and resources together and realize a shared goal. The recently launched What Women Want campaign is especially motivating given its potential to transform accountability for reproductive and maternal health at the global and national levels.
KENILWORTH, N.J., June 27, 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, through its Merck for Mothers initiative announced study results on an investigational heat-stable formulation of carbetocin for the prevention of excessive bleeding after childbirth, also known as postpartum haemorrhage (PPH).
by Dr. Neel Shah, Assistant Professor at Harvard Medical School
As an obstetrician, my job is to focus on moms and babies. But one of my favorite parts of childbirth is the look on a new dad’s face at the precise moment he sees his baby for the first time. The physical connection between moms and babies begins sooner and more gradually than it does for dads. Moms feel their babies growing and wriggling months before they get to actually see them. For dads, the first physical connection is visual. Fatherhood goes from being abstract to very real in an instant. And that look is everything.
At Merck for Mothers, we believe that actionable research is essential for taking on maternal mortality. On behalf of our team and many partners, we are pleased to share Evidence for Impact, our first Research Compendium. The publications included in this compendium advance our collective understanding of the problem of maternal mortality, inform the design and implementation of programs aiming to improve women’s health, and strengthen the global health community of practice to save women’s lives.
Merck for Mothers lead Dr. Naveen Rao has announced his intent to retire on July 1. Dr. Rao has led Merck for Mothers since its inception, and was responsible for leveraging Merck's scientific and business expertise to accelerate the program's progress. Dr. Mary-Ann Etiebet, currently the executive director, will succeed Dr. Rao.
The world’s resources are finite. Over the next few decades the demand for energy, clean water and natural resources will increase substantially due to population growth and economic development. As a result, there will be fewer resources available to support the world’s growing needs. In addition, air and water pollution continue to adversely impact human health, causing respiratory and water-borne illnesses. At Merck, we are working to find new ways to reduce our use of natural resources and lower our environmental impacts.
We sat down with Merck for Mothers Executive Director, Dr. Mary Ann-Etiebet, to hear about the progress that has been made, why she joined the company last year, and what’s next for the global initiative.
Can you give a brief explanation of Merck for Mothers and the initiative’s goals?
Corporate Responsibility Magazine has ranked Merck #22 on its 19th annual 100 Best Corporate Citizens list. The list recognizes the standout environmental, social and governance (ESG) performance of public companies across the United States.
In the year or so since ProPublica and NPR published their first article in the “Lost Mothers” series, close to 5,000 Americans have come forward with accounts of how a loved one had died – or they themselves had nearly died – during pregnancy or childbirth.